Prostate Cancer Treatments—Do The Dollars Create Value? - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Evaluating the Value of Financial Investment in Prostate Cancer Treatments

  • By

  • Charles L. Bennett

  • Chadi Nabhan

  • September 10, 2026

Share

  • 1

    Prostate cancer-related spending increased from $504 million in 2012 to $1.9 billion in 2021, marking a fourfold rise.

  • 2

    In 2021, systemic therapies accounted for 74% of prostate cancer expenditures, totaling $1.4 billion.

  • 3

    Second-generation androgen receptor pathway inhibitors represented 64% of total prostate cancer expenditures in 2021.

  • 4

    The shift in prostate cancer management has moved from local interventions to extended systemic treatments.

  • 5

    Shen and colleagues' study utilized the Surveillance, Epidemiology, and End Results–Medicare linked database from 2012 to 2021.

Original Source(s)

Prostate Cancer Treatments—Do The Dollars Create Value?

  • by Charles L. Bennett, Chadi Nabhan

  • September 10, 2026

Related Content

Dynamic clonal evolution of multiple bypass resistance mechanisms in EGFR-mutant lung adenocarcinoma: a case report

Clinician Counseling and Weight Loss Attempts Among Survivors of Obesity-Associated Cancers

Case Report: Donor-derived early T-cell precursor acute lymphoblastic leukemia following an allogeneic hematopoietic stem cell transplantation for pediatric severe aplastic anemia